rTS 6.0: New Traceability Solution

rfxcel Traceability System 6.0:  New Traceability Solution Delivers Improved User Experience and Performance

 

San Ramon, February 7, 2018 – rfxcel, the leader in Life Science track and trace, and compliance systems, today announced the release of rfxcel Traceability System (rTS) 6.0.  The new traceability software delivers increased usability and performance which is powered by the new rTS 6.0 architecture and technology stack.

rTS 6.0 is built upon an enhanced architecture that provides greater scalability; allowing new features to be quickly added.  The new product gives users improved visibility into their supply chain via a new, highly responsive user interface (UI) and enhanced report features. Better search capabilities, menu navigation, event relationships, event notifications and alerts, and user configuration options have been added as part of the functional and UI improvements.  rTS 6.0 has been further optimized to deliver up to 3X performance improvement for critical processes.
To learn more, visit https://www.rfxcel.com/rfxcel-traceability-software-release-6-0/

“rTS 6.0’s cutting-edge architecture makes fast, easy data insight a reality for all customers. We’re incredibly proud of the work the rfxcel team has done to deliver this game-changing serialization and compliance technology, and most importantly, make it a seamless upgrade for our customers. rfxcel brings increased visibility and flexibility to supply chain traceability and product serialization, making data more assessable than ever before.” – Atul Mohidekar Chief Technology Officer at rfxcel.

The rTS 6.0 platform is designed to simplify and accelerate how customers can meet their compliance, serialization and track and trace requirements. By leveraging a new architecture and optimization techniques, customers can be confident that their investment will meet their current obligations and scale to meet their future needs.

To learn more about how we can help you with your needs for compliance, serialization, and track and trace, please visit us at www.rfxcel.com.

 

For more information, contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

Technically Certified Connection Provider for EMVO

San Ramon, December 21, 2017 – rfxcel, a global Track & Trace company, has been confirmed as a EMVO Technically Certified Connection Provider. This provides the ability for pharmaceutical manufacturers to use rfxcel to connect their product master data to the European Hub, and to meet EU Falsified Medicine Directive (FMD) serialization and compliance requirements.

The European Medicines Verification System (EMVS) is a pan-European system operated by EMVO, to enable medicines to be verified at the point of dispensing. Under the terms of the EU Falsified Medicines Directive (FMD) from 9th February 2019, Marketing Authorization Holders within the FMD’s jurisdiction will be required to upload their product serialization data via the EMVS European Hub.

As a Technically Certified Connection Provider, rfxcel will enable Marketing Authorization Holders to capture and report their serialized data and related transactions to the European Hub via a validated, secure and cost-effective solution.

“This marks another major milestone for rfxcel as we continue to grow to meet the traceability and regulatory needs of the pharmaceutical industry in Europe.  We are excited to offer the most flexible and feature-rich solution to aid EMVO in its mission to protect the drug supply chain”, said Glenn Abood, CEO of rfxcel.

As the pioneer and leader in traceability solutions for the Life Sciences industry, rfxcel provides its customers with a robust and sophisticated platform with a low total-cost-of-ownership. The EMVO certification – combined with a recent $30M growth capital infusion, the acquisition of Frequentz assets, and important key hires in Europe – widens the Company’s lead as the most versatile player in the industry.

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their platform enables companies to protect patients, comply with regulatory mandates, and gain visibility into their supply chain. rfxcel’s relentless commitment to customer success and continuous innovation ensures that companies can meet today’s requirements and tomorrow’s challenges.

 

Contact information:

Herb Wong, VP of Marketing

hwong@rfxcel.com

www.rfxcel.com

Leaders in Track and Trace Join rfxcel Executive Team

As part of rfxcel’s continued commitment to serve its global customers, rfxcel is pleased to announce that key leaders in track and trace join rfxcel Executive Team to drive global growth.

Jim Moore joins rfxcel as Senior VP of Corporate Development and GM of International Operations.

Jim has been an advisor to rfxcel, led the Company’s recent $30M capital raise with Kayne Partners, facilitated rfxcel’s entry into new geographies such as India and Europe, and completed the asset purchase from Frequentz. Jim has a unique track record of success in enterprise technology operations, analysis and investment banking.

“I am excited to bring my experience to drive international growth, partnerships, and M&A to further rfxcel’s mission to combat counterfeit pharmaceuticals, food and other products critical to the consumer”, said Moore.

“Jim has been invaluable in helping us formulate our capitalization and growth strategies and we are very pleased to have his experience and creativity added to our senior management team”, said Glenn Abood, CEO.

Simon Manley joins rfxcel as its new Commercial Director for Europe.

Simon will be responsible for driving rfxcel’s overall sales strategy and offerings to both existing and new clients in Europe. Simon will oversee marketing, strategic business partnerships and sales for Europe.

Simon joins from Oracle, where he was Sales Director for EMEA in the Health Sciences Global Business Unit, resulting in a huge expansion in sales growth across Europe, Middle East and Africa. Prior to this he was Vice President of Sales and Marketing at McKesson, a pharmaceutical distributor and the 5th highest revenue generating company in the US.

Commenting on the new appointment, Jim Moore said: “Simon brings relevant know-how to rfxcel and will be an asset to the management team. His knowledge of sales, customer satisfaction and international experience will be invaluable as we look to grow our presence in Europe.”

Manley commented: “I look forward to expanding rfxcel’s business both in Europe and globally. rfxcel’s commitment to customer success and continuous innovation ensures that customers meet their requirements and protect those who depend on them.  I am proud to be working with a team that can deliver all of this”

As the pioneer and leader in track and trace solutions for the Life Sciences market, rfxcel provides solutions to ensure customer success and secure their supply chain.

 

For more information contact us:

Herb Wong, VP Marketing

hwong@rfxcel.com

rfxcel.com

 

About rfxcel:

As the pioneer and leader in track and trace solutions for the Life Sciences, rfxcel provides solutions to improve the safety, quality, and security throughout the Life Sciences supply chain.

rfxcel Acquires Frequentz Assets

rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is pleased to announce the acquisition of assets from Frequentz, Inc., a leading player in life science and food traceability. This combination will bring new benefits to prospective and existing customers.

Under this agreement, rfxcel acquires Frequentz technology, patents, contracts and personnel.  This acquisition enables rfxcel to retain some of the industry’s most talented and knowledgeable personnel in serialization and traceability solutions. rfxcel will assume customer relationships and support for all Frequentz customers in the Pharmaceutical and Food industries.

This combined organization will extend rfxcel’s customer list to include some of the largest manufacturers and wholesalers in the world. This positions rfxcel as the largest independent traceability provider for the Life Sciences and Food industries offering full data and system validation.

“We are thrilled to be joining the leader in this space and to bring food traceability to the global market. We have spent many years developing this market and the combined entity will be the best positioned player in this fast growing industry”, said Charlie Sweat, founder of Frequentz.

“This acquisition will add to our expanding footprint in the global Life Sciences space and launch us into the Food industry. We are very pleased to now offer the world’s most sophisticated product Serialization and Traceability platform to the food industry to ensure consumer safety and enhance supply chain visibility” according to Glenn Abood, CEO of rfxcel.

The acquisition of the Frequentz assets is effective on December 5th, 2017.  Key resources from Frequentz will be transitioned to rfxcel as part of this effort to ensure a seamless experience for all customers.

As the pioneer and leader in track and trace solutions for the Life Sciences industry, rfxcel has developed a highly scalable platform for supply chain visibility, anti-counterfeiting and compliance. This acquisition combined with a recent $30M growth capital infusion and important key hires widens the Company’s lead as the strongest player in the industry.

 

For more information contact us:

Herb Wong, VP of Marketing

hwong@rfxcel.com

www.rfxcel.com

Patient Safety Through Traceability

Global pharmaceutical safety
through smart serialization and open collaboration

 

Medications – we all use them, but how can we be sure they are authentic and safe? 10-15% of the world’s drug supply is counterfeit. Criminals mislabel drugs to scam consumers, selling the fake drug as authentic. The pharmaceutical industry loses hundreds of billions in profit. Hundreds of thousands of patients are at risk of losing their lives every year.

 

The need for pharmaceutical companies to have absolute and accurate visibility of their supply chains is imperative. Global governments are demanding complete visibility into a drug’s journey from manufacturer to patient. The industry is shifting from a simple buyer-seller model to a more collaborative model. This is only possible through a Platform that is interoperable throughout the entire supply chain.

 

“This collaborative model supports the pharmaceutical industry’s need for companies to view each other as allies. rfxcel is committed to open collaboration that works with all partners, governments, and standard bodies such as GS1 and HDA. It is important to enable effective interoperability and not pursue a closed network that drives proprietary standards. By supporting the open exchange of information, companies do not have to worry about future integrations needs. Instead, companies can focus on meeting the needs of their customers and keeping their products safe.”
– Herb Wong, VP of Product Management at rfxcel.

 

rfxcel offers a global traceability solution which enables the entire pharmaceutical supply chain to track and trace products. rfxcel Traceability System can offer traceability from the raw-material supplier to the dispenser, delivering the final product safely to the end user. With over fourteen years in the pharmaceutical supply chain business, rfxcel knows that true visibility is only possible by integrating and processing data thoroughly between manufacturers, distributors, packagers, clinics and pharmacies. rfxcel works to ensure data is valid.

 

“With each step in the process, we run over sixty data verifications to reduce bad data entering the supply chain. We continuously put best data integration practices into effect, improving accuracy and visibility of the supply chain. Each shipment is assigned a serial number. At every handoff the receiving party scans that number. rfxcel instantly ascertains the data, providing a digital report with data points about the product and its history. We aggregate the date in a relationship hierarchy, so recipients gain complete visibility into every pallet, case and bottle. This process ensures trading partners feel confident that medications are authentic and safe.”
– Herb Wong, VP of Product Management at rfxcel.

 

Today, the rfxcel Traceability Platform provides a global solution to eliminate threats such as counterfeiting, product diversion, and theft. It is a flexible and reliable system that reduces the cost and difficulty of implementing traceability technology. rfxcel has strong experience and knowledge of industry standards, and has partnerships with regulatory agencies. This provides the solution that manufacturers and pharmaceutical companies need.

 

About rfxcel:

rfxcel is the leading provider of SaaS-based track and trace solutions. Their solution enables companies to protect patients and meet their compliance needs, while getting insights and visibility into their supply chain. Their relentless commitment to customer success and continuous innovation ensures that companies meet their requirements and protect those who depend on them.

rfxcel Drives EU Expansion with Industry Experts

rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories. The company, which already has a presence in 4 continents, announced on Monday that it will accelerate its global expansion to operate throughout Europe.

rfxcel is staffed with industry leaders that understand the importance of data accuracy, global compliance and serialization processing. This approach has made rfxcel the leader in traceability and serialization.

Mark Davison is a leading expert and published author in Serialization and EU Pharma technologies. He will head up the rfxcel team in the European territories as the Senior Director of Operations for Europe.

“Data accuracy matters in serialization. Unfortunately, experience tells us that most solution providers only push data and events through without verifying if it meets regulations, or even check for duplication in generating serial numbers. At rfxcel we believe that customers need to think of accurate data processing from the beginning and we provide a more active data validation approach as standard.” – Mark Davison, Senior Director of Operations Europe.

rfxcel will be hosting a discussion at the Pharma TrackTS! 2017 conference in Berlin September 28th and 29th. Mark Davison and rfxcel’s Chief Strategy Officer, Jack Tarkoff, will be speaking about the importance of data validation and its effects on supply chain management.  

As the pioneer and leader in track and trace solutions for the Life Sciences, rfxcel provides solutions to ensure customer success and secure their business. rfxcel is excited to help fulfill the serialization and compliance needs within Europe.

For more information contact us:
Herb Wong, VP Marketing
hwong@rfxcel.com
rfxcel.com

RFXCEL RAISES $30 MILLION IN SERIES B FINANCING.

San Ramon, CA – August 3, 2017 – rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners. Kayne Partners is the growth private equity group of Kayne Anderson Capital Advisors, L.P., an alternative investment firm managing over $25 billion in assets.

 

rfXcel plans to use this investment to accelerate the delivery of innovative supply chain solutions; increase resources to extend its successful Internet of Things (“IoT”) partnership with Verizon; and expand its global geographical presence in the Americas, Europe, Middle East and Asia Pacific. Founded in 2003, rfXcel has been providing mission-critical solutions to life sciences customers longer than any provider in this space. Because of its tenure and commitment to innovation, rfXcel offers the most feature-rich solution and flexible platform in the market.

 

rfXcel offers customers a long-term strategic solution to gain insight and visibility into their supply chains,” said Leon Chen, Managing Director of Kayne Partners, who will join rfXcel’s board of directors as part of this financing. “rfXcel has developed a track record of building great technology and partnering with customers in life sciences and other industries to build strong business relationships and solve complex challenges.”

 

We are excited to team with Kayne Partners,” said Glenn Abood, Co-Founder and CEO of rfXcel. “rfXcel has the longest track record in meeting the supply chain visibility and regulatory needs in the life sciences industry. This partnership allows rfXcel to accelerate its market growth and extend its leading edge technology. With the accelerated changes in technology and shifting market needs, rfXcel will continue to lead the industry with its technology platform and laser focus on customer success. Our mission is to protect patients and combat the illegal counterfeit pharmaceutical market and this capital provides us with the means to broaden our reach in this battle.”

 

About rfXcel:
rfXcel is the leading provider of SaaS based track and trace solutions that enables customers to protect patients and meet their compliance needs while getting insights and visibility into their supply chain. Its relentless commitment to customer success and continuous innovation ensures that customers meet their requirements and protect those who depend on them.

 

About Kayne Partners

Kayne Partners is a leading provider of capital and connections to rapidly growing companies in North America. Since its inception more than a decade ago, it has invested over $600 million in platform investments and add-on acquisitions. Kayne Partners seeks to partner with driven entrepreneurs as a non-control minority investor and provide transformative capital to these high growth companies. Kayne Partners is the growth private equity group of Kayne Anderson Capital Advisors, L.P.

For more information, visit www.kaynepartners.com

 

About Kayne Anderson Capital Advisors, L.P.

Kayne Anderson Capital Advisors, L.P., founded in 1984, is a leading alternative investment management firm focused on niche investing in upstream oil and gas companies, energy and infrastructure, specialized real estate, growth equity and both private credit and diversified liquid credit. Kayne Anderson manages over $25 billion in assets and employs over 300 professionals in eight offices across the U.S.

Kayne Anderson is headquartered in Los Angeles with offices in Houston, New York City, Chicago, Denver, Dallas, Atlanta and Boca Raton.

For more information, visit www.kaynecapital.com

 

Contacts

Kayne Partners:
Leon Chen, Managing Director
310.282.2834 or lchen@kaynecapital.com

rfXcel:
Herb Wong, Head of Marketing
925.791.3235 or hwong@rfxcel.com

rfXcel Announces Promotion of Brian Bilyeu to Vice President of Sales.

San Ramon, California, January 4, 2017- rfXcel the leader in serialization, traceability, and DSCSA and global compliance for the Pharmaceutical and Life Sciences industries, today announced the promotion of Brian Bilyeu to the position of Vice President of Sales. Mr. Bilyeu joined rfXcel in 2015 during that time he has been instrumental in contributing to the company’s unprecedented growth within the pharmaceutical industry. As Vice President of Sales, Bilyeu will be responsible for leading rfXcel’s sales team and developing new business opportunities both domestically and globally. Mr. Bilyeu brings over 30 years of leadership experience in sales & sales management, supply chain operations and IT leadership.

“I am looking forward to this expanded role and continuing to be part of an innovative organization that maintains its success by focusing on the needs of customers,” said Brian Bilyeu.

“Brian’s promotion is well-deserved recognition of the role he has played in the development and exponential growth of key accounts,” said Glenn Abood, Founder and CEO of rfXcel. “Brian’s leadership and experience make him ideally suited to lead our sales force and the continued growth in our core vertical markets.”

About rfXcel:
rfXcel Corporation, headquartered in San Ramon, CA is a leader in improving the safety, quality, and security throughout the Life Sciences supply chain. rfXcel provides supply chain product traceability that reduces operating costs, increases revenue and significantly decreases the potential introduction of counterfeit drugs. Our private cloud-based rfXcel Traceability System (rTS) is an easy to use solution that provides timely, accurate supply chain tracing information and requires no upfront data manipulation to implement. Unlike other solutions, rTS validates your tracking data and our private cloud solution eliminates the need for re-validation, you choose when to upgrade. Compliant with DSCSA and global government regulations, you will have complete visibility and traceability through your supply chain. Partner with rfXcel to access the most flexible, feature-rich traceability solution available today.

rfXcel and Be4ward Announce a Webinar to Address the November 2017 DSCSA Serialization Requirements for Contract Manufacturers (CMO’s).

San Ramon, California, November 2, 2016- rfXcel and Be4ward announce that they will co-host an informative webinar on November 16, 2016 for Contract Manufactures. This session will help clarify some of the confusion Contract Manufactures are facing when it comes to meeting the DSCSA requirements by November 17, 2017. The webinar will address the key areas of the law that must be met, practices to incorporate, what trading partners are looking for, and how you can accelerate compliance while creating value for your company.

The session will be co-presented with Stephen McIndoe, VP and serialization expert at Be4ward. Stephen will show how to accelerate the process to meet the fast approaching DSCSA deadline.

“There are many issues to master in preparing for DSCSA serialization deadlines”, said Glenn Abood, Founder and CEO of rfXcel. “rfXcel has helped a range of providers meet their serialization requirements with seamless integration on our private cloud network that was built from the outset for maximum speed and scalability. With the ability to integrate with any ERP system without the need for middleware platforms we can help CMO’s meet the November 2017 deadline. With database normalization and validation we reduce data redundancy and improve integrity while connecting you to your trading partners with ease.”

Don’t be left behind, register today for this informative webinar at: www.rfxcel.com or www.be4ward.com

 

About rfXcel:

rfXcel Corporation, headquartered in San Ramon, CA is a leader in improving the safety, quality, and security throughout the Life Sciences supply chain. rfXcel provides supply chain product traceability that reduces operating costs, increases revenue and significantly decreases the potential introduction of counterfeit drugs.  Our private cloud-based rfXcel Traceability System (rTS) is an easy to use solution that provides timely, accurate supply chain tracing information and requires no upfront data manipulation to implement.  Unlike other solutions, rTS validates your tracking data and our private cloud solution eliminates the need for re-validation, you choose when to upgrade. Compliant with DSCSA and global government regulations, you will have complete visibility and traceability through your supply chain. Partner with rfXcel to access the most flexible, feature-rich traceability solution available today.

 

About Be4ward:

Be4ward is a niche consultancy company helping pharmaceutical, biotech and medical device companies and their supply base improve their serialization, labeling and artwork capabilities. Be4ward help clients define the most efficient business processes, organization design and, being completely independent, help them select and implement the most appropriate service providers and IT systems to meet their needs. If you would like more information about this topic, please contact Stephen McIndoe on email at Stephen.mcindoe@be4ward.com. Corporate website: www.be4ward.com

rfXcel Awarded Group Purchasing Agreement with Premier to Deliver DSCSA Compliance and Peace of Mind for Premier Members

rfXcel SNAP product will be made available to all Premier members at preferred pricing

San Ramon, Calif. & Charlotte, N.C., July 26, 2016 – rfXcel, the leader in serialization, traceability, and DSCSA and global compliance for the Pharmaceutical and Life Sciences industries, today announced it has reached a new group purchasing agreement with Premier Inc., a leading healthcare improvement company. Under the agreement, rfXcel will offer rfXcel SNAP, its DSCSA compliance software solution specifically for dispensers, to Premier acute care, continuum of care and REACH™ members at pre-negotiated and preferred pricing and terms.

Premier, which operates a national group purchasing organization (GPO), enables better care and outcomes at a lower cost for its approximately 3,600 U.S. hospitals and 120,000 other providers. rfXcel SNAP is the easiest and most automated compliance management solution for pharmaceutical dispensers to comply with DSCSA regulations. The application is designed to make it simple, easy and fast to receive and enter product information from manufacturers and/or wholesalers and distributors. Premier members have the opportunity to join thousands of other dispensers across the US in using rfXcel SNAP to help them comply with DSCSA dispenser regulations and gain peace of mind.

“We’re pleased Premier members have selected rfXcel SNAP as a recommended DSCSA compliance solution for the Premier alliance. rfXcel SNAP is already bringing value to thousands of dispensers, and our agreement with Premier further demonstrates our dedication and commitment to helping pharmaceutical dispensers become DSCSA compliant and ultimately helping to ensure patient safety,” commented Glenn Abood, Founder and CEO of rfXcel. “We look forward to helping Premier deliver on its mission of enabling better care and outcomes at a lower cost for its members.”

About rfxcel

rfXcel Corporation, headquartered in San Ramon, CA, is a pioneer in creating Product Serialization, Traceability and Compliance private cloud solutions for the Life Sciences industry. Leading manufacturers, distributors, packagers, dispensers and retailers leverage rfXcel solutions to meet global government regulations, track and trace product throughout supply chains, and enhance patient safety.

 

CONTACT:

Jack Tarkoff

rfxcel Corp.

925-915-1039

jtarkoff@rfxcel.com